CRSP icon

CRISPR Therapeutics

380 hedge funds and large institutions have $2.54B invested in CRISPR Therapeutics in 2023 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 102 increasing their positions, 120 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

4% less funds holding

Funds holding: 396380 (-16)

15% less repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 120

16% less first-time investments, than exits

New positions opened: 48 | Existing positions closed: 57

Holders
380
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$79.7M
Puts
$71.8M
Net Calls
Net Calls Change

Top Sellers

1 -$13.2M
2 -$11.7M
3 -$10M
4
AC
Armistice Capital
New York
-$9.59M
5
UBS Group
UBS Group
Switzerland
-$9.21M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$855K
127
$854K
128
$844K
129
$842K
130
$812K
131
$781K
132
$751K
133
$737K
134
$715K
135
$713K
136
$709K
137
$649K
138
$647K
139
$630K
140
$573K
141
$565K
142
$565K
143
$563K
144
$560K
145
$554K
146
$552K
147
$534K
148
$529K
149
$529K
150
$524K